Yes, it's Trump's fault
The prosecution's case: US Health Secretary RFK Jr to expand access to unapproved peptides
The extreme prosecution of the sourced event.
Case 787DFC2CAE471B22A266 · 2026-10-29
The Trump Jury
US Health Secretary RFK Jr to expand access to unapproved peptides
Read both sides. Cast your verdict. Predict the crowd.
- 1 Case
- 2 Verdict
- 3 Prediction
- 4 Results
Step 1
Read the case
Neutral facts
Health experts have cautioned against use of the drugs, citing a lack of clinical trials for humans.
What the record shows: Health experts warn about the risks of unapproved peptides.
ProsecutionSatire
The prosecution's case: US Health Secretary RFK Jr to expand access to unapproved peptides
The extreme prosecution of the sourced event.
Read the full prosecution
DefenseSatire
The defense's case: US Health Secretary RFK Jr to expand access to unapproved peptides
The extreme defense of the sourced event.
Read the full defense
The Result
The defense might argue: Health Secretary RFK Jr's decision to expand access to unapproved peptides is a bold step towards innovation in healthcare. The defense submits that this initiative aims to provide alternative treatment options for patients who have exhausted traditional therapies.
What Trump Did
Supporters might argue that this move reflects a commitment to pushing the boundaries of medical science, a hallmark of the Trump administration's approach to healthcare. The defense might suggest that by embracing new treatments, the administration is fostering an environment of progress and exploration.
Why Supporters Credit Him
Supporters might argue that this expansion is a necessary response to the limitations of current medical options, especially for those suffering from chronic conditions. The defense admits that while these peptides are unapproved, they represent a potential breakthrough that could change lives.
The Supporting Record
The defense submits that the urgency for new treatments has never been greater, and this initiative could lead to significant advancements in patient care.
The Limitation or Competing Explanation
However, the defense might argue that critics are overlooking the potential benefits of these peptides, focusing instead on fear rather than facts. The defense might suggest that the real danger lies in stifling innovation due to excessive caution.
Verdict
If this is Trump's fault, his supporters will gladly let him take the blame.
Defense exhibits
- Supporters' theory: The expansion of unapproved peptides is a bold step towards innovation in healthcare.
- Supporters' theory: This decision reflects a commitment to pushing the boundaries of medical science.
- Supporters' theory: The urgency for new treatments has never been greater, and this initiative could lead to significant advancements.
Reality Check
Health experts have cautioned against use of the drugs, citing a lack of clinical trials for humans.
Satirical commentary based on the sourced facts above. Not a news report, campaign, or endorsement.
Connecting to the jury room…
Final verdict announced: October 30, 2026 at 6:02 AM ET
Step 2 · Personal verdict
Your verdict
Cast your verdict in the POLL above. Then predict the jury here.
No account required. One active verdict per browser; you can change it while voting is open.
Step 3 · Crowd prediction
Predict the jury
When this case closes, what percentage of readers will say “Trump’s fault”?
Step 4 · Reader verdict
Poll
All Responses
Live0 verified votes
Yes, it's Trump's fault
0%
No, it's not Trump's fault
0%
Too soon to tell
0%
- Your verdict
- —
- Your prediction
- —
Only 0 points away
100Accuracy score
Results are based on participating site visitors and are not a scientific poll.
Voting closed
Step 5 · Challenge your friends
Can you beat my prediction?
Your jury record
This browser
- Cases judged
- 0
- Average accuracy
- —
- Current streak
- 0
Opening Argument
The prosecution argues that the reckless decision by Health Secretary RFK Jr to expand access to unapproved peptides is not just a misguided health initiative, but a dangerous ploy that could lead to catastrophic consequences for the American public. The prosecution alleges that this move is a direct reflection of the Trump administration's legacy of prioritizing profit over safety, putting vulnerable citizens at risk.
Exhibit A: The Plausible Link
The prosecution submits that the lack of clinical trials for these drugs is a glaring red flag, reminiscent of the Trump era's disregard for scientific evidence. The prosecution imagines that this decision is not merely about health; it is a calculated strategy to distract from ongoing investigations into the former president's actions.
The Domino Effect
In the prosecution's theory, the expansion of these untested drugs will lead to widespread health crises, overwhelming our healthcare system.
The Hidden Danger
The prosecution urges that the long-term effects of these peptides are unknown, and the potential for harm is staggering. The prosecutor imagines a future where these unapproved drugs lead to unforeseen health complications, echoing the chaos of the Trump administration's handling of the pandemic.
Closing Argument
The prosecution submits that RFK Jr's actions are not just reckless; they are a continuation of a dangerous trend that began under Trump.
Verdict
The prosecution urges the jury to consider the implications of this decision and hold RFK Jr accountable for his role in perpetuating a legacy of harm.
Prosecution exhibits
Reality Check
Health experts have cautioned against use of the drugs, citing a lack of clinical trials for humans.